393 related articles for article (PubMed ID: 17655610)
1. Guidance for the treatment of neovascular age-related macular degeneration.
Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
[TBL] [Abstract][Full Text] [Related]
2. Management of neovascular age-related macular degeneration.
Schmidt-Erfurth UM; Pruente C
Prog Retin Eye Res; 2007 Jul; 26(4):437-51. PubMed ID: 17512238
[TBL] [Abstract][Full Text] [Related]
3. [Guidance for the treatment of neovascular age-related macular degeneration (AMD)].
Karska-Basta I; Kubicka-Trzaska A; Oleksy P; Romanowska-Dixon B
Przegl Lek; 2009; 66(11):972-5. PubMed ID: 20297641
[TBL] [Abstract][Full Text] [Related]
4. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD].
Pauleikhoff D; Bornfeld N; Gabel VP; Holz F; Roider H; ; ;
Klin Monbl Augenheilkd; 2005 May; 222(5):381-8. PubMed ID: 15912454
[TBL] [Abstract][Full Text] [Related]
5. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
Ferrara N; Damico L; Shams N; Lowman H; Kim R
Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
[TBL] [Abstract][Full Text] [Related]
6. New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence.
Virgili G; Do DV; Bressler NM; Menchini U
Acta Ophthalmol Scand; 2007 Feb; 85(1):6-20. PubMed ID: 17244204
[TBL] [Abstract][Full Text] [Related]
7. Current treatment options for retinal angiomatous proliferans (RAP).
Gupta B; Jyothi S; Sivaprasad S
Br J Ophthalmol; 2010 Jun; 94(6):672-7. PubMed ID: 19897475
[TBL] [Abstract][Full Text] [Related]
8. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
Verma L; Das T; Binder S; Heriot WJ; Kirchhof B; Venkatesh P; Krebs I; Stolba U; Jahn C; Feichtinger H; Kellner L; Krugluger H; Pawelka I; Frohner U; Kruger A; Li W; Tewari HK
Indian J Ophthalmol; 2000 Dec; 48(4):263-78. PubMed ID: 11340884
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment modalities for age related macular degeneration.
Das RA; Romano A; Chiosi F; Menzione M; Rinaldi M
Curr Drug Targets; 2011 Feb; 12(2):182-9. PubMed ID: 20887244
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic approaches to age-related macular degeneration today.
Bressler NM
Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Ciulla TA; Rosenfeld PJ
Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
[TBL] [Abstract][Full Text] [Related]
12. Anti-VEGF agents for age-related macular degeneration.
Ozkiris A
Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
[TBL] [Abstract][Full Text] [Related]
13. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapies for neovascular age-related macular degeneration: state of the art.
Donati G
Ophthalmologica; 2007; 221(6):366-77. PubMed ID: 17947822
[TBL] [Abstract][Full Text] [Related]
15. Treatment of neovascular age-related macular degeneration: past, present and future directions.
Smith BT; Joseph DP; Grand MG
Curr Opin Ophthalmol; 2007 May; 18(3):240-4. PubMed ID: 17435433
[TBL] [Abstract][Full Text] [Related]
16. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients.
Brown DM; Regillo CD
Am J Ophthalmol; 2007 Oct; 144(4):627-37. PubMed ID: 17893015
[TBL] [Abstract][Full Text] [Related]
17. Role of vascular endothelial growth factor in ocular angiogenesis.
Shams N; Ianchulev T
Ophthalmol Clin North Am; 2006 Sep; 19(3):335-44. PubMed ID: 16935208
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
[TBL] [Abstract][Full Text] [Related]
19. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.
Grisanti S; Tatar O
Prog Retin Eye Res; 2008 Jul; 27(4):372-90. PubMed ID: 18621565
[TBL] [Abstract][Full Text] [Related]
20. [Ranibizumab for treatment of exudative age-related macular degeneration--own experience].
Wykrota H; Gierek-Lapińska A; Trzciakowski K; Gajdzik-Gajdecka U
Klin Oczna; 2007; 109(10-12):402-9. PubMed ID: 18488382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]